223 related articles for article (PubMed ID: 33028902)
1. Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis.
Kwan T; Kazamel M; Thoenes K; Si Y; Jiang N; King PH
Sci Rep; 2020 Oct; 10(1):16679. PubMed ID: 33028902
[TBL] [Abstract][Full Text] [Related]
2. The vitamin D activator CYP27B1 is upregulated in muscle fibers in denervating disease and can track progression in amyotrophic lateral sclerosis.
Si Y; Kazamel M; Kwon Y; Lee I; Anderson T; Zhou S; Bamman M; Wiggins D; Kwan T; King PH
J Steroid Biochem Mol Biol; 2020 Jun; 200():105650. PubMed ID: 32142934
[TBL] [Abstract][Full Text] [Related]
3. Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis.
Si Y; Cui X; Crossman DK; Hao J; Kazamel M; Kwon Y; King PH
Neurobiol Dis; 2018 Jun; 114():85-94. PubMed ID: 29486297
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
[TBL] [Abstract][Full Text] [Related]
5. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of DJ-1 and PINK1 in sporadic ALS and in the SOD1(G93A) ALS mouse model.
Knippenberg S; Sipos J; Thau-Habermann N; Körner S; Rath KJ; Dengler R; Petri S
J Neuropathol Exp Neurol; 2013 Nov; 72(11):1052-61. PubMed ID: 24128678
[TBL] [Abstract][Full Text] [Related]
7. Assessment of metal concentrations in the SOD1
Enge TG; Ecroyd H; Jolley DF; Yerbury JJ; Kalmar B; Dosseto A
Mol Cell Neurosci; 2018 Apr; 88():319-329. PubMed ID: 29524628
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis.
Pigna E; Simonazzi E; Sanna K; Bernadzki KM; Proszynski T; Heil C; Palacios D; Adamo S; Moresi V
EBioMedicine; 2019 Feb; 40():717-732. PubMed ID: 30713114
[TBL] [Abstract][Full Text] [Related]
9. Wnt and extraocular muscle sparing in amyotrophic lateral sclerosis.
McLoon LK; Harandi VM; Brännström T; Andersen PM; Liu JX
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5482-96. PubMed ID: 25125606
[TBL] [Abstract][Full Text] [Related]
10. Carboxyl-terminal modulator protein regulates Akt signaling during skeletal muscle atrophy in vitro and a mouse model of amyotrophic lateral sclerosis.
Wang J; Fry CME; Walker CL
Sci Rep; 2019 Mar; 9(1):3920. PubMed ID: 30850672
[TBL] [Abstract][Full Text] [Related]
11. Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production.
Muller FL; Song W; Jang YC; Liu Y; Sabia M; Richardson A; Van Remmen H
Am J Physiol Regul Integr Comp Physiol; 2007 Sep; 293(3):R1159-68. PubMed ID: 17584954
[TBL] [Abstract][Full Text] [Related]
12. Impaired bone homeostasis in amyotrophic lateral sclerosis mice with muscle atrophy.
Zhu K; Yi J; Xiao Y; Lai Y; Song P; Zheng W; Jiao H; Fan J; Wu C; Chen D; Zhou J; Xiao G
J Biol Chem; 2015 Mar; 290(13):8081-94. PubMed ID: 25648889
[TBL] [Abstract][Full Text] [Related]
13. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
[TBL] [Abstract][Full Text] [Related]
14. Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model.
Luo G; Yi J; Ma C; Xiao Y; Yi F; Yu T; Zhou J
PLoS One; 2013; 8(12):e82112. PubMed ID: 24324755
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor antagonism accelerates disease onset in the SOD1
McLeod VM; Lau CL; Chiam MDF; Rupasinghe TW; Roessner U; Djouma E; Boon WC; Turner BJ
Br J Pharmacol; 2019 Jul; 176(13):2111-2130. PubMed ID: 30849180
[TBL] [Abstract][Full Text] [Related]
16. Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis.
Bowerman M; Salsac C; Coque E; Eiselt É; Deschaumes RG; Brodovitch A; Burkly LC; Scamps F; Raoul C
Hum Mol Genet; 2015 Jun; 24(12):3440-56. PubMed ID: 25765661
[TBL] [Abstract][Full Text] [Related]
17. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Sharp PS; Dick JR; Greensmith L
Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
[TBL] [Abstract][Full Text] [Related]
18. Functional over-load saves motor units in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis.
Gordon T; Tyreman N; Li S; Putman CT; Hegedus J
Neurobiol Dis; 2010 Feb; 37(2):412-22. PubMed ID: 19879358
[TBL] [Abstract][Full Text] [Related]
19. Transforming Growth Factor Beta (TGF-β) Is a Muscle Biomarker of Disease Progression in ALS and Correlates with Smad Expression.
Si Y; Kim S; Cui X; Zheng L; Oh SJ; Anderson T; AlSharabati M; Kazamel M; Volpicelli-Daley L; Bamman MM; Yu S; King PH
PLoS One; 2015; 10(9):e0138425. PubMed ID: 26375954
[TBL] [Abstract][Full Text] [Related]
20. FGF23, a novel muscle biomarker detected in the early stages of ALS.
Si Y; Kazamel M; Benatar M; Wuu J; Kwon Y; Kwan T; Jiang N; Kentrup D; Faul C; Alesce L; King PH
Sci Rep; 2021 Jun; 11(1):12062. PubMed ID: 34103575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
